Guggenheim Capital’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$232K Sell
13,067
-35,645
-73% -$562K ﹤0.01% 1603
2026
Q1
$699K Buy
48,712
+34,622
+246% +$575K 0.01% 1105
2025
Q4
$249K Buy
+14,090
New +$233K ﹤0.01% 1608
2022
Q4
– Sell
-42,752
Closed -$291K – 1981
2022
Q3
$291K Buy
+42,752
New +$711K ﹤0.01% 1670

Other funds holding SHC

Guggenheim Capital's SHC Position: Q2 2026 in Review

Guggenheim Capital reduced its Sotera Health (SHC) stake by 73% in Q2 2026, selling an estimated $562K and leaving 13,067 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1603.

Guggenheim Capital first reported a position in SHC in Q3 2022 and has held it in 4 quarters since. The position peaked at $699K in Q1 2026. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Guggenheim Capital held 13,067 shares of Sotera Health worth $232K as of Q2 2026.
  • Guggenheim Capital sold 35,645 Sotera Health shares in Q2 2026, an estimated $562K.
  • Sotera Health made up ﹤0.01% of Guggenheim Capital's portfolio in Q2 2026, its #1603 holding.
  • Guggenheim Capital first reported a position in Sotera Health in Q3 2022 and has held it in 4 quarters since.
  • Guggenheim Capital's Sotera Health position peaked at $699K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.